DNTH insider trades & Congress trades
Dianthus Therapeutics, Inc. /DE/: public insider filings and Congress disclosures, in one place.
Bourse has recorded 30 open-market insider transactions in Dianthus Therapeutics, Inc. /DE/ (DNTH) (0 purchases with code P and 30 sales with code S), the most recent on September 17, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 21 sales by 5 ($7.75M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Carr Edward | CHIEF ACCOUNTING OFFICER | Sell | 7,928 | $100.43 | $796K | −0.2% |
| Sep 17, 2026 | Carr Edward | CHIEF ACCOUNTING OFFICER | Sell | 6,771 | $101.37 | $686K | −0.2% |
| Sep 17, 2026 | Carr Edward | CHIEF ACCOUNTING OFFICER | Sell | 3,501 | $102.39 | $358K | −0.2% |
| Sep 17, 2026 | Carr Edward | CHIEF ACCOUNTING OFFICER | Sell | 1,100 | $103.20 | $114K | −0.2% |
| Sep 17, 2026 | Carr Edward | CHIEF ACCOUNTING OFFICER | Sell | 700 | $104.39 | $73K | −0.2% |
| Sep 1, 2026 | Randhawa Simrat | EVP, Head of R&D | Sell | 2,600 | $105.19 | $273K | −0.2% |
| Sep 1, 2026 | Randhawa Simrat | EVP, Head of R&D | Sell | 7,215 | $106.25 | $767K | −0.2% |
| Sep 1, 2026 | Randhawa Simrat | EVP, Head of R&D | Sell | 13,309 | $106.74 | $1.42M | −0.2% |
| Aug 19, 2026 | Read Simon | – | Sell | 2,778 | $117.55 | $327K | −0.1% |
| Aug 10, 2026 | Veness Adam M | SVP, General Counsel and Sec. | Sell | 16,167 | $110.38 | $1.78M | −0.1% |
| Aug 10, 2026 | Read Simon | – | Sell | 70 | $107.11 | $7K | −0.1% |
| Aug 10, 2026 | Read Simon | – | Sell | 737 | $108.17 | $80K | −0.1% |
| Aug 10, 2026 | Read Simon | – | Sell | 831 | $108.95 | $91K | −0.1% |
| Aug 10, 2026 | Read Simon | – | Sell | 272 | $109.96 | $30K | −0.1% |
| Aug 10, 2026 | Read Simon | – | Sell | 470 | $111.05 | $52K | −0.1% |
| Aug 10, 2026 | Read Simon | – | Sell | 397 | $111.77 | $44K | −0.1% |
| Aug 10, 2026 | McGeorge Anne | – | Sell | 1,450 | $107.58 | $156K | −0.1% |
| Aug 10, 2026 | McGeorge Anne | – | Sell | 2,800 | $108.38 | $303K | −0.1% |
| Aug 10, 2026 | McGeorge Anne | – | Sell | 1,800 | $109.30 | $197K | −0.1% |
| Aug 10, 2026 | McGeorge Anne | – | Sell | 1,000 | $110.64 | $111K | −0.1% |
| Aug 10, 2026 | McGeorge Anne | – | Sell | 700 | $111.41 | $78K | −0.1% |
| Aug 7, 2026 | Garcia Marino | CEO AND PRESIDENT | Sell | 10,384 | $107.49 | $1.12M | +0.0% |
| Aug 7, 2026 | Garcia Marino | CEO AND PRESIDENT | Sell | 23,907 | $108.05 | $2.58M | +0.0% |
| Aug 7, 2026 | Garcia Marino | CEO AND PRESIDENT | Sell | 2,373 | $109.10 | $259K | +0.0% |
| Aug 7, 2026 | Garcia Marino | CEO AND PRESIDENT | Sell | 2,536 | $110.02 | $279K | +0.0% |
| Aug 7, 2026 | Garcia Marino | CEO AND PRESIDENT | Sell | 800 | $110.76 | $89K | +0.0% |
| Aug 7, 2026 | Garcia Marino | CEO AND PRESIDENT | Sell | 104,091 | $107.96 | $11.2M | +0.0% |
| Aug 7, 2026 | Garcia Marino | CEO AND PRESIDENT | Sell | 21,909 | $108.72 | $2.38M | +0.0% |
| Aug 7, 2026 | Veness Adam M | SVP, General Counsel and Sec. | Sell | 3,217 | $110.61 | $356K | −0.1% |
| Aug 7, 2026 | Veness Adam M | SVP, General Counsel and Sec. | Sell | 616 | $111.18 | $68K | −0.1% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.